Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reisch

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
BMC Public Health|February 1, 2011
Drug suicide: a sex-equal cause of death in 16 European countriesAiri Värnik, Merike Sisask, Peeter Värnik, et al.
Viruses|August 30, 2018
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 InfectionTeresa I Ng, Tami Pilot-Matias, Rakesh Tripathi, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2016
Discovery of fluorobenzimidazole HCV NS5A inhibitorsJohn T Randolph, Charles A Flentge, Pamela Donner, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor GlecaprevirTeresa I Ng, Rakesh Tripathi, Thomas Reisch, et al.
Journal of Affective Disorders|July 16, 2008
Gender issues in suicide rates, trends and methods among youths aged 15-24 in 15 European countriesAiri Värnik, Kairi Kõlves, Jüri Allik, et al.
Journal of Medicinal Chemistry|May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitorsJohn T Randolph, Charles A Flentge, Peggy P Huang, et al.
Journal of Medicinal Chemistry|April 15, 2018
Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)Rolf Wagner, John T Randolph, Sachin V Patel, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
BMC Public Health|February 1, 2011
Drug suicide: a sex-equal cause of death in 16 European countriesAiri Värnik, Merike Sisask, Peeter Värnik, et al.
Viruses|August 30, 2018
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 InfectionTeresa I Ng, Tami Pilot-Matias, Rakesh Tripathi, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2016
Discovery of fluorobenzimidazole HCV NS5A inhibitorsJohn T Randolph, Charles A Flentge, Pamela Donner, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor GlecaprevirTeresa I Ng, Rakesh Tripathi, Thomas Reisch, et al.
Journal of Affective Disorders|July 16, 2008
Gender issues in suicide rates, trends and methods among youths aged 15-24 in 15 European countriesAiri Värnik, Kairi Kõlves, Jüri Allik, et al.
Journal of Medicinal Chemistry|May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitorsJohn T Randolph, Charles A Flentge, Peggy P Huang, et al.
Journal of Medicinal Chemistry|April 15, 2018
Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)Rolf Wagner, John T Randolph, Sachin V Patel, et al.
Pageof 5